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Abstract The ubiquitous transcription factor Spl has been im- 
plicated in the mechanism which maintains CpG islands methyla- 
tion-free. Plasmids containing GC boxes (Spl sites) were in vitro 
methylated at every CpG dinucleotide. After stable introduction 
into F9 embryonal carcinoma cells, we analysed the methylation 
of the sequence around the GC boxes with bisulphite sequencing. 
In agreement with restriction site analysis by other labs, we found 
preferential demethylation at GC box DNA versus control DNA. 
However, the bisulphite sequencing which permits the analysis of 
every CpG site on a given DNA molecule, revealed a complex 
pattern of methylated and unmethylated sites. Upon prolonged 
culture the pattern became simpler, with most sites demethylated 
but certain sites being consistently methylated. 
pies of CpG islands that remain methylation free but contain 
no Spl sites (A. Bird, personal communication). 
Using bisulphite sequencing, we show that, despite the re- 
quirement of Spl sites for protection of a CpG island from 
methylation [9,10], the presence of an Spl site per se is not 
sufficient o keep surrounding DNA free from methylation. 
Furthermore, starting with DNA methylated at all CpGs by 
SssI methylase, we analysed the demethylation of CpG dinu- 
cleotides in a 50-bp window containing GC boxes or mutated 
GC boxes. We show that the demethylation of this heavily 
metbylated substrate is unexpectedly complex and individual 
CpGs can remain methylated in the close vicinity of an Spl site. 
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1. Introduction 
CpG islands are approximately 500 to 2000 bp long and form 
a distinctive compartment of the mammalian genome which, in 
contrast o the bulk of genomic DNA, is not depleted in CpG 
dinucleotides [1,2,3]. They are associated with approximately 
half of mammalian genes [4], often in promoter and leader 
regions [2,5], and are usually methylation free throughout de- 
velopment [6]. How CpG islands maintain this unmethylated 
state is an open question. 
The mammalian transcription factor Spl has long been sus- 
pected to play a role in maintaining CpG islands methylation 
free [7]. The 10-bp consensus Spl binding site is (G/T)(G/ 
A)GG(C/A)G(G/T)(G/A)(G/A)(C/T) [8], and its core sequence, 
GGGCGG or GC box, are commonly found in CpG islands 
[2]. Recent evidence shows the involvement of Sp 1 binding sites 
in demethylation [9,10]. In embryonic stem (ES) cells, sub- 
fragments of the adenine phosphoribosyltransferase (aprt) 
CpG island that had been methylated by HpalI methylase in 
vitro became demethylated in an Spl site dependent manner [9]. 
Furthermore, in transgenic mice the aprt CpG island remained 
methylation free provided it contained functional Spl binding 
sites [9,10]. It was shown by using restriction enzymes, that the 
probability of demethylation at a given CpG dinucleotide in ES 
cells decreases with distance from an Spl site. Other transcrip- 
tion factors, of course, may also be involved as there are exam- 
*Corresponding author. Fax: (41) (1) 363 8502. 
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2. Materials and methods 
2.1. Plasmid constructs 
The GC box oligonucleotide used here contains two tandem Spl 
binding site sequences from the ICP4 promoter of herpes implex Virus. 
The GC box oligo is: 
5"-CGAGCCGGCCCCGCCCATCCCCGGCCCCGCCCATCG-3", 
3'-TCGAGCTCGGCCGGGGCGGGTAGGGGCCGGGGCGGGT- 
AGCAGCT-5', 
and the GCmut oligo, which is the same as the GC box oligo except 
for two point mutations (indicated inlower case) within the Sp I binding 
site, is: 5"-CGAGCCGGCaC~GCCCATCCCCGGCaCsGCCCATC- 
G-3', 3'-TCGAGCTCGGCCGtGcCGGGTAGGGGCCGtGcCGGG- 
TAGCAGCT-5". 
These oligonucleotides were inserted into the plasmid GOVEC 
[11,12] to construct the target plasmids GC-OVEC and GCmut-OVEC. 
2.2. Bandshifts 
Nuclear extracts were prepared as previously described [13]. The 
single Spl binding site was 5'-CGAGCCGGCCCCGCCCATC-3', 3'- 
TCGAGCTCGGCCGGGGCGGGTAGAGCT-5'. 4 fmol of probe 
end-labelled with T4 polynucleotide kinase (New England Biolabs) was 
incubated with 5 pg nuclear extract, and 2 Pg poly(dI-dC) in a total 
volume of 15/A at RT for 15 min. The binding buffer was 12 mM Hepes, 
pH 7.9, 12% glycerol, 5 mM NaCI, 50 mM KCI, 5 mM MgC12, 0.6 mM 
DTT and 100 pM ZnSO 4 [14] for GC box and GCmut binding. Super- 
shifts were performed in the same binding buffer and in addition 0.6 
~1 of either antiSp 1, antiSp3 or pre-immune s ra [15] was added 10 min 
into the incubation. 
2.3. Bisulphite sequencing 
Essentially, the previously published protocol [16] was followed, with 
the light protection suggested in [17]. 2/lg of genomic DNA or 1 ng 
plasmid DNA was denatured with 0.3 M NaOH for 15 min at 37°C and 
the freshly prepared 3.1 M sodium bisulphite, pH 5, was added irectly 
to the denatured DNA, mixed well and placed under mineral oil. The 
reaction mixture was then incubated for 12 h at 50°C, boiled for 4 min 
and reincubated for a further 2 h at 50°C. The samples were then placed 
on ice. The mineral oil was removed and 6/11 of glass milk was added 
to the reaction mix. The samples were rotated slowly at 4°C for 30 min. 
After washing at 4°C, the glass milk (Geneclean) was allowed to dry 
for 5 min and then incubated at 50°C in 100 pl 5 mM EDTA, pH 5 for 
2 min. The samples were quickly spun and the supernatant was imme- 
diately added to 11 pl 2 M NaOH and incubated at 20°C for 20 min. 
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The reaction was neutralised with 47 f l  10 M NH4Ac, precipitated with 
300 f l  EtOH and resuspended in 100 f l  TE, pH 8. 
2.4. PCR 
The reaction volume was 50 fl ,  with 80 fM dNTPs, 200 fM primers, 
0.4 U Supertaq (P.H. Stehelin) and the recommended reaction buffer 
except for 20 mM pH 9 AMPSO and 800 fM MgC12. A hot start was 
performed at 85°C, followed by 95°C for 1 min 20 s, 58°C for 1 min 
and 72°C for 1 min for 3 cycles and 95°C for 40 s, 52°C for 50 s and 
72°C for 1 min for 28 cycles in a cycler (Omnigene). 
Primer sequences were: 
AOV-XbalO 5'-ACT CTAGATCACTAAACAAATAC AC-3", 
AOV-Eco l 6 5"- TAAGAATTCTTTTTTTA TTA GGAA GATTT- 
A TTTT-3', 
AOV-Eeo26 5C-C~AATTCGTATTTATAATTATGGTATAGGT-3 ", 
AOV-Bam20 5'-CGGGATCCACA-ATTATATCAAAAACAAAT-3'. 
Nucleotides in italics represent nucleotides in the original vector 
OVEC [12]. Underlined and bold nucleotides represent bisulphite con- 
version and introduced restriction sites respectively. The amplified se- 
quences were cloned into pKSS [18] following EcoRI/Xba I or EcoRI/ 
BamHI double digestion. 
Sequencing was done with SK primer either on an ABI sequencing 
machine and Taq polymerase or manually using Sequenase (UBS). 
2.5. Southern blots 
High molecular weight genomic DNA was isolated from a 10 cm 
diameter plate of F9 cells as described [19]. Blots were hybridised with 
the riP-labelled HindlI1 XhoI probe (Fig. 1) and a Phospho-imager 
(Molecular Dynamics) was used to quantify the intensity of bands. To 
calculate the percentage of demethylation the formula '% demethyla- 
tion = 0.9-kb HpalI band intensity/(0.9-kb HpalI band intensity + 4.2- 
kb HindlII band intensity)' was used. 
2.6. DNA transfections 
F9 cells were cultured in DMEM medium supplemented with 10% 
fetal calf serum (GibcoBRL), 100 U/ml penicillin and 50 pg/ml strepto- 
mycin. The F9 cells were always kept in a non-confluent and undiffer- 
entiated state [20]. Stable F9 transfections were performed by co-trans- 
fecting 3 fig of OVEC-based plasmid and 0.3 fg  of the puromycin 
resistance vector pBSpacAP [21] with LipofectAMINE (7 fl/ml) 
(GibcoBRL) and then selecting for transformants with 0.4 fg/ml of 
puromycin (Sigma) for I0 days. Colonies were pooled. Second round 
transfections were performed with the neomycin resistance vector 
pMC1NeoPolyA (Stratagene) and stable transformants were selected 
for with 0.5 mg/ml of G418 (GibcoBRL). 
2. 7. In vitro methylation 
SssI and HpaII methylases were purchased from New England Bio- 
labs. Mock methylation was performed by omitting the enzyme. Com- 
pleteness of methylation of plasmid DNA, and oligonucleotides, was 
checked with HpalI digestion and agarose gel electrophoresis. Plasmid 
DNAs used for transfection were also checked with bisulphite sequenc- 
ing. 
3. Results 
3.1. The factors Spl and Sp3 are present & F9 cells and bind to 
a GC box regardless ofmethylation 
In bandshift experiments using nuclear extracts from F9 
cells, at least three distinct prote in-DNA complexes were de- 
tected with the GC-box oligo but only weakly with the mutated 
GC box (Fig. 1B). The specificity of the three bands was dem- 
onstrated with competition by excess GC box oligonucleotide 
(data not shown). To identify the nature of the bands we per- 
formed a supershift experiment using antibodies raised specifi- 
cally against he transcription factors Spl or Sp3 [15], with both 
F9 and control Hela nuclear extracts. In both extracts, the 
slowest migrating band contained Spl and the two faster mi- 
grating complexes contained Sp3. Therefore, the transcription 
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Fig. 1. Schematic representation f the eukaryotic segment of the plas- 
mids, GC-OVEC and GCmut-OVEC. (A) The 0.84-kb HindlII-XhoI 
probe and bands visualized with Southern blotting are shown below the 
restriction map. TATA box and the transcription start are indicated. 
Hind: HindlII, H: HpalI/MspI. In the lower part of the figure a CpG 
density plot of a 1.85-kb region containing the GC box or GCmut 
sequences i depicted. (B) Bandshift performed with GCmut oligonncle- 
otide and an oligonucleotide containing a single GC box. Similar esults 
were obtained with the GC box oligo that contained two binding sites. 
Lanes 1 7, F9 nuclear extract; lanes 1 and 2 contain Mock and SssI 
methylated end-labelled GC box oligo respectively; lanes 3 and 4 Mock 
and SssI methylated GCmut oligo, respectively; lanes 5-11 a non- 
methylated GC box oligo. Lanes 5 10 contain specific antibody to 
Sp 1 (aSp 1), Sp3 (~Sp3), or pre-immune serum (pre) as indicated. Lanes 
8-11, HeLa nuclear extract. The lowest fastest migrating band that was 
shifted by the anti-Sp3 antibody could sometimes be resolved into 2 
bands. 
factors Spl and Sp3 are present in F9 cells and bind specifically 
to the GC box oligonucleotide whether it is methylated or not. 
An incidental finding of this study was that the binding of 
transcription factor Sp3 is not inhibited by methylation of its 
binding site (Fig. 1B, lane 2), similarly to previous findings with 
the transcription factor Spl [7,22]. 
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Fig. 2. Southern blot analysis ofgenomic DNA recovered from F9 cells 
stably transformed with either mock or SssI methylated GC-OVEC, or 
mock or SssI methylated GCmut-OVEC. Sizes are indicated in kb. -: 
HindIII digestion alone, H: HindIII and HpaII double digestion, M: 
HindIII and MspI double digestion. Lanes 1-3 genomic DNA recov- 
ered from F9 cells stably transfected with mock methylated GC-OVEC, 
lanes 4-5 mock methylated GCmut-OVEC, lanes 6-8 SssI methylated 
GC-OVEC, lanes 9-11 SssI methylated GCmut-OVEC. 
3.2. Demethylation fSssI in vitro methylated Spl sites 
determined by Southern analysis 
F9 cells were stably transfected with either SssI methylated 
GC-OVEC, SssI methylated GCmut-OVEC, mock methylated 
(i.e. unmethylated) GC-OVEC, or mock methylated GCmut- 
OVEC, as described in section 2. Genomic DNA was purified 
and digested with HindIII alone or in combination with either 
the methylation sensitive HpaII or methylation insensitive 
MspI. 
The percentage of demethylation was quantified using a 
phospho-imager as described in section 2. The HpaII digestion 
revealed that the SssI methylated GC-OVEC became demethyl- 
ated by 41%, (Fig. 2, lane 7), whereas only 23% of the GCmut 
oligo was demethylated, (Fig. 2, lane 10). Therefore, in agree- 
ment with previous observations [9], intact GC boxes indeed 
enhanced emethylation. Further, the Southern blot shows that 
GC boxes inhibited de novo methylation as the mock methyl- 
ated GC-OVEC became de novo methylated to 30% but the 
GCmut-OVEC was de novo methylated to 60% (Fig. 2, lanes 
2 and 5). Since both the GC box and GCmut oligonucleotides 
contain two HpaII sites in close proximity to each other (Fig. 
1A), digestion at one site cannot be distinguished from diges- 
tion at the other. Thus, to observe the 0.9-kb band that shows 
whether demethylation f SssI methylated DNA has occurred 
in the GC box oligonucleotides, only one of the two sites need 
to be demethylated. On the other hand, to observe the HpaII 
resistant 4.2-kb band that reveals de novo methylation of the 
originally unmethylated plasmid, both sites must become de 
novo methylated. The Southern blot therefore gives an indica- 
tion of GC box function in promoting demethylation a d par- 
tially preventing de novo methylation. 
3.3. Bisulphite sequencing of GC boxes 
The samples that had been analysed by Southern blot were 
examined by bisulphite sequencing [23], which allows the posi- 
tive identification of methyl cytosines from individual genomic 
DNA molecules [23]. Consistent with the results that we ob- 
tained by Southern blotting, demethylation in the GC box con- 
taining construct was high, with approximately 60% of CpGs 
becoming demethylated, whereas a significantly lower amount 
was observed in the mutated GC box containing construct (20% 
of CpGs, Fig. 3A). The individual promoters did not reveal any 
noteworthy pattern of demethylation, with the promoters 
showing many possible combinations of remaining methyl 
CpGs. Consistent with the Southern blot, the mock-methyl- 
ated, i.e. unmethylated GC-OVEC construct became only spo- 
radically de novo methylated, in contrast o the mock methyl- 
ated GCmut-OVEC construct which, in different cell clones, 
either remained unmethylated or became de novo methylated 
to a high extent, (Fig. 3B). 
To examine the effect of prolonged culture on demethylation, 
we further studied the methylation status of the SssI methylated 
GC-OVEC constructs after a further 2 weeks of culture. To 
avoid any possible bias, which might have arisen due to a small 
number of clonal cells outgrowing other cells, we selected a 
sub-population of the cells containing SssI methylated GC- 
OVEC by the transfection of a neomycin resistance gene cas- 
sette followed by G418 selection for a period of 2 weeks. Over 
300 resistant colonies from three separate transfections were 
pooled and genomic DNA was bisulphite sequenced. The ex- 
tent of demethylation was now greater with 75% of CpGs 
becoming demethylated (Fig. 3C); this was also consistent with 
a Southern blotting (data not shown). The pattern of the re- 
maining methyl CpGs was, however, surprising. Even though 
the starting methylation status of the integrated plasmid before 
this second round of selection was in all probability diverse, the 
methylation status after this further round of selection was 
much more homogeneous. In particular, the site 3' to the pro- 
moter was uniformly demethylated and 2 CpGs, one actually 
between the 2 GC boxes, were consistently methylated. 
4. Discussion 
Although many immortalised cell lines have a proportion of 
methylated CpG islands, the CpG islands of embryonic arci- 
noma (EC) and embryonic stem (ES) cell lines obey the general 
rule that CpG islands are unmethylated [24]. It is consistent 
with analyses performed in EC and ES cells [25,26], and results 
obtained in developing mice [6], that the unmethylated state of 
CpG islands is established uring a critical period of high 
demethylation activity that occurs early in development. The 
establishment and maintenance of the unmethylated state may 
require an activity that can recognise methyl CpGs in CpG 
islands and remove them. EC cells can efficiently convert 
methyl CpGs present at low density in CpG islands to unmeth- 
ylated CpG [27], probably via an excision repair activity [28]. 
Such situations, where a CpG island contains a low level of 
methylation, would occur if sites in a CpG island became acci- 
dentally methylated. 
Transcription factors have recently been implicated in the 
establishment and maintenance of the unmethylated state of 
CpG islands [9,10]. Spl has long been suspected to play such 
a role [7] because it can bind to a GC box regardless of meth- 
ylation; and we show incidentally that Sp3 also appears to be 
insensitive to methylation of its binding site. Transcription fac- 
tors might establish or maintain CpG islands by, among other 
possibilities, merely excluding the DNA methyltransferase, or 
alternatively by creating a secondary molecular flag, such as 
ordered chromatin [10], which either excludes methyltrans- 
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F ig .  3. Schematic representation f the bisulphite sequencing results. 
(A) Sequences of promoters from SssI in vitro methylated plasmids, 
GC-OVEC and GCmut-OVEC, recovered from stably transfected F9 
cells, m, CpG dinucleotide remained methylated, CpG dinucleotide 
became demethylated. (B) Sequences of promoters from mock methyl- 
ated plasmids, GC-OVEC and GCmut-OVEC, recovered from stably 
transfected F9 cells, u, CpG dinucleotide remained unmethylated, m, 
CpG dinucleotide became de novo methylated. (C) Sequences of GC- 
OVEC promoters originally in vitro methylated with SssI methylase 
and recovered from stably transfected F9 cells further selected with 
G418. m, CpG dinucleotide r mained methylated, CpG dinucleotide 
became demethylated. 
ferase or attracts a demethylase activity. Whatever the mecha- 
nism is, it is still not clear, as in the case of the mouse aprt gene 
promoter, how it is that three Spl sites clustered at the 3' end 
of the CpG island maintain a methylation free zone of 1-kb 
upstream [10]. Our results emphasise that the GC box induced 
demethylation bserved in the EC cell system does not encom- 
pass every CpG in the neighbourhood of GC boxes, and indi- 
vidual promoters may contain different patterns of methyl 
groups I0 days after transfection, although after a further two 
weeks a quite uniform pattern of methylated and unmethylated 
sites is observed. In our experiment it was difficult o assess the 
role of transcription itself, as opposed to mere binding of tran- 
scription factor, as the transcription from GC-OVEC was not 
significantly above the basal level (data not shown). 
High density methylated substrates do exist naturally [29], in 
the dosage compensated X-chromosome and become demeth- 
ylated, probably during the transition from oogonia to oocyte 
[30]. It is interesting to note that F9 EC cells can reactivate the 
inactive X-chromosome of mice thymocytes [31] when fused as 
somatic ell hybrids. This experiment is not immediately recon- 
cilable with another in F9 cells that shows that an SssI methyl- 
ated CpG island, with a high density of in vitro introduced 
methyl CpGs, is very inefficiently demethylated when stably 
transfected into F9 cells [27]. A possible reconciliation lies in 
the observation that not all CpGs in a CpG island need neces- 
sarily be methylated on the inactive X-chromosome; with the 
frequency of methylation at each of the 32 CpGs in the hprt 
CpG island varying from 3-100% on the inactive X-chromo- 
some [29]. Thus, although SssI methylase has the same CpG 
dinucleotide specificity as the mammalian methyltransferase, a 
CpG island methylated at every CpG might not provide a real 
substrate for a demethylation activity in vivo. We were able to 
observe significant demethylation of SssI methylated DNA, 
however, and this may be because our constructs were designed 
so that the GC boxes were surrounded by DNA with a low 
G + C%, (20%), and low CpG content, (O/E = 0.2), see Fig. 1A. 
EC and ES cells paradoxically contain both a high demethyl- 
ation activity and a high de novo methylation activity [32,33]. 
We show that two GC boxes can promote demethylation, and 
can partially protect hese short sequences themselves from the 
high de novo methylation observed in F9 cells, Furthermore we 
show that mutated GC boxes were less able to promote low 
level demethylation, and at the same time, were less able to 
protect hemselves from the high de novo methylation activity. 
It is not obvious whether a GC box can only enhance deme- 
thylation or can also directly interfere with de novo methyla- 
tion. Whatever the mechanism, it is clear that although Spl sites 
174 J. Silke et al./FEBS Letters 370 (1995) 170-174 
are required to maintain the CpG island of the aprt gene in a 
methylation free state [9,10], the presence of Spl binding sites 
per se does not cause complete demethylation or complete 
protection of surrounding DNA from methylation. Further 
analysis is necessary to determine whether a completely un- 
rnethylated or completely methylated substrate, transfected 
into F9 cells, over a long culture period eventually converge to 
obtain the same pattern of methylcytosines which may be char- 
acteristic for any particular sequence. 
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